BR9107173A - COMPLEXES OF POLYAMINE AND RESIN DRUGS - Google Patents

COMPLEXES OF POLYAMINE AND RESIN DRUGS

Info

Publication number
BR9107173A
BR9107173A BR919107173A BR9107173A BR9107173A BR 9107173 A BR9107173 A BR 9107173A BR 919107173 A BR919107173 A BR 919107173A BR 9107173 A BR9107173 A BR 9107173A BR 9107173 A BR9107173 A BR 9107173A
Authority
BR
Brazil
Prior art keywords
polyamine
complexes
drugs
resin
resin drugs
Prior art date
Application number
BR919107173A
Other languages
Portuguese (pt)
Inventor
William Joseph Kelleher
Anthony Earl Carpanzano
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of BR9107173A publication Critical patent/BR9107173A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
BR919107173A 1990-12-21 1991-12-16 COMPLEXES OF POLYAMINE AND RESIN DRUGS BR9107173A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63229090A 1990-12-21 1990-12-21
PCT/US1991/009463 WO1992011038A1 (en) 1990-12-21 1991-12-16 Polyamine drug-resin complexes

Publications (1)

Publication Number Publication Date
BR9107173A true BR9107173A (en) 1993-11-16

Family

ID=24534913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919107173A BR9107173A (en) 1990-12-21 1991-12-16 COMPLEXES OF POLYAMINE AND RESIN DRUGS

Country Status (17)

Country Link
EP (1) EP0563294A1 (en)
JP (1) JPH06504059A (en)
CN (1) CN1063221A (en)
AU (1) AU663695B2 (en)
BR (1) BR9107173A (en)
CA (1) CA2098200A1 (en)
CZ (1) CZ119793A3 (en)
FI (1) FI932842A0 (en)
HU (1) HUT74642A (en)
IE (1) IE914513A1 (en)
MX (1) MX9102753A (en)
MY (1) MY107811A (en)
NO (1) NO932212L (en)
NZ (1) NZ241097A (en)
PT (1) PT99912A (en)
SK (1) SK59493A3 (en)
WO (1) WO1992011038A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7668894A (en) * 1993-08-13 1995-03-14 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
DE69432867T2 (en) * 1993-11-18 2004-04-22 Sirtex Medical Ltd., Burswood PREPARATION WITH CONTROLLED RELEASE
ES2097087B1 (en) * 1994-08-01 1997-12-16 Univ Sevilla CONTROLLED RELEASE SYSTEM FOR MORPHINE AND OTHER PHARMACLES SOLUBLE IN WATER BY COMPLEXING WITH POLYMERIC SUBSTANCES.
PT946145E (en) * 1996-12-20 2008-10-17 Mcneil Ppc Inc Antitussive drugs delivered by ion exchange resins
UA73092C2 (en) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Tablets with enteric coating and method for their manufacture
KR20020016069A (en) * 2000-08-24 2002-03-04 민경윤 An oral composition of a macrolide antibiotic and a process for preparing same
WO2005023217A2 (en) * 2003-09-03 2005-03-17 Mallinckrodt Inc. Granular sustained release preparation and production thereof
CN100415297C (en) * 2006-08-28 2008-09-03 浙江大学 Zinc supplements based on cation exchange resin and its preparation method and use
CN100411629C (en) * 2006-08-28 2008-08-20 浙江大学 Slow-released type iron-complement agent, prepn. method and use thereof
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
WO2015076821A1 (en) * 2013-11-22 2015-05-28 Tris Pharma, Inc. Novel clonidine formulation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
FR2634377B1 (en) * 1988-06-30 1991-09-27 Cortial NOVEL EXTENDED RELEASE PHARMACEUTICAL FORM BASED ON AN ACTIVE RESIN-PRINCIPLE COMPLEX
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes

Also Published As

Publication number Publication date
WO1992011038A1 (en) 1992-07-09
CA2098200A1 (en) 1992-06-21
NO932212L (en) 1993-08-20
FI932842A (en) 1993-06-18
MY107811A (en) 1996-06-29
CN1063221A (en) 1992-08-05
HUT74642A (en) 1997-01-28
NO932212D0 (en) 1993-06-16
IE914513A1 (en) 1992-07-01
NZ241097A (en) 1994-11-25
HU9301819D0 (en) 1993-09-28
FI932842A0 (en) 1993-06-18
PT99912A (en) 1993-01-29
MX9102753A (en) 1992-06-30
EP0563294A1 (en) 1993-10-06
AU663695B2 (en) 1995-10-19
SK59493A3 (en) 1993-11-10
CZ119793A3 (en) 1994-01-19
AU9168791A (en) 1992-07-22
JPH06504059A (en) 1994-05-12

Similar Documents

Publication Publication Date Title
BR1100824A (en) Pharmaceutical composition and composition
NO942923L (en) drugs
DK0616523T3 (en) drugs
NO305786B1 (en) drug Package
KR950703566A (en) Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
NO930677L (en) PHARMACEUTICAL RELATIONS
NO923859D0 (en) DRUG
MX9100447A (en) REDUCTION AND PREVENTION OF DRUG SENSITIZATION
DE498268T1 (en) 5-OXO-L-PROLINE DERIVATIVES AND THEIR PHARMACEUTICAL PRODUCTIONS.
BR9200058A (en) PHARMACEUTICAL COMPOUND AND COMPOSITION
PT551048E (en) 2-IMIDAZOLINE-5-ONA DERIVATIVES AND 2-IMIDAZOLINE-5-TIONS FUNGICIDES
DE69324288T2 (en) Accelerometer and angular accelerometer
BR9107173A (en) COMPLEXES OF POLYAMINE AND RESIN DRUGS
DE69304107D1 (en) Polyamide resin composition and connectors
DE69333528D1 (en) D-N-CARBAMOYLAMINOSAUREAMIDOHYDROLASE AND HYDANTOINASE
DE69116600T2 (en) Polyamide resin and polyamide resin compositions
NO304890B1 (en) Pharmaceutical compounds and pharmaceutical preparations
NO931008D0 (en) PHARMACEUTICAL RELATIONS
DE69116650D1 (en) Polyimide resin and its preparation
FI955605A0 (en) Aryling drug
BR8805034A (en) RESIN MODIFIER AND MODIFIED RESIN
BR9106582A (en) TETRAZOL DERIVATIVES AND MEDICINES
BR8904915A (en) EPOXIDE RESIN COMPOSITION AND APPLICATION
BR9100866A (en) RESIN AND COPOLIESTER RESIN COMPOSITION
NO175630C (en) Drug packing and combination packing

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: A61K 47/58 (2017.01)